Validating Adolescent SBIRT Measures

Completed

Conditions studied: Substance Abuse

In brief

The purpose of this study is to address the needs for efficient and informative measurement for evaluating adolescent Screening, Brief Intervention, and Referral to Treatment (SBIRT) strategies. The investigators will undertake a longitudinal cohort study to build and validate a substance specific measurement battery that includes patient-centered and intermediary outcomes which can be integrated into a range of healthcare and research settings. The results of this project will enable evaluation of SBIRT trials and clinical efforts by validating a parsimonious set of measurement tools that can be incorporated into electronic health records. The primary goal of the proposed project is to develop a set of brief, valid tools that will allow both researchers and clinicians to collect information that enables evaluating and refining brief interventions. The main objective is to define and disseminate a set of brief and easy to administer measures that accurately detect 1) substance use frequency, 2) substance-specific patient centered outcomes and 3) intermediate measures of impact of adolescent SBIRT. The specific aim addressed in this project is to develop and administer an assessment battery that includes novel questions assessing substance use to be validated against criterion standard measures both cross-sectionally and longitudinally.

Key facts

Study ID

NCT02981849

Run by

Boston Children's Hospital

People needed

514

Starts

2016-01-01

Expected to finish

2019-12-01

Last updated by the study team

2020-01-27

Who can join

Age: 14 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 14-17 year-old youth presenting for routine medical care at the Adolescent and Young Adult clinic at BCH, with informed assent/consent.
• To be eligible, youth must be between 14-17 years old at the time of enrollment and be able to read and understand English at a middle school level or greater.
• Participants must consent to participation in the study and consent to the 6 month and 12 month follow up assessments.

You may not qualify if…

• Patients who are medically or emotionally unstable or otherwise unable to assent/consent at the time of their appointment as determined by their clinician or the research team, those who are unable to speak/read English at a middle school reading level, use a computer keyboard and/or complete an interviewer-assisted questionnaire will be excluded.
• Participants who do not consent to 6 month and 12 month re-assessment will also be excluded.
• Patients who are pregnant at baseline will be excluded from the study.
• If a participant enrolls in the study and becomes pregnant after baseline, the participant will not be excluded from the follow up assessments.

Where it is running

• Boston Children's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.